Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07679477

Management of Myopia in University Students With DIMS-TED Spectacle Lenses

The purpose of the study is to quantify the effectiveness of Hoya MiyoSmart IQ (DIMS-TED) spectacle lenses in slowing the rate of myopia progression in university students.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–23 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Bradford, Bradford, West Yorkshire, United Kingdom

Loading trial locations.

About this study

MiyoSmart spectacle lenses have been shown to be a safe and effective way of managing myopia progression in children aged 8-12 years. However, myopic progression is not limited to children of this age group and there is evidence that progression also occurs in university students. The researchers are therefore investigating the effectiveness of this intervention in a group of UK-based University students.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Myopic students studying at university
  • Aged 18-23 years at the start of the study
  • Show evidence of axial length growth of at least 0.06mm prior to entry into Stage 2 of the study.
  • Have read the patient information sheet and be happy to sign the consent forms
  • Be willing to adhere to the visit schedule and wearing times described in the protocol
  • Agree to accept either the control or test lenses as assigned by the randomisation
  • Have BCVA of +0.10 LogMAR or better in each eye

Exclusion criteria

  • Previous myopia control use (optical or pharmacological)
  • Amblyopia
  • Myopic Rx up to -10D
  • Astigmatism up to 4D
  • Anisometropia <1.75D
  • Binocular Vision anomalies (such as tropia)
  • Taking medications that affect pupil size or accommodation
  • A known allergy to tropicamide

Treatment and study plan

DIMS TED spectacle lenses

Device

Spectacle lenses for myopia management

Single vision spectacle lenses

Device

Single vision spectacle lenses as control

Primary outcomes

  1. Axial length

    Time frame: 24 months

    Change in axial length relative to baseline

  2. Cycloplegic SER

    Time frame: 24 months

    Change in spherical equivalent cycloplegic autorefraction relative to baseline

Sponsors and collaborators

Lead sponsor

University of Bradford

Other

Collaborators

  • Hoya Vision Care
  • University of Huddersfield

Registry information

Official study title

Management of Myopia in University Students Using Defocus Incorporated Multiple Segment (DIMS) Spectacle Lenses.

Acronym: MoMUS-DIMS

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Jul 1, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.